Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Contracting favors platforms that document outcomes and control medication-related spend
It is used for the treatment of type 2 diabetes and associated cardiovascular complications
Patients experiencing these symptoms should seek same-day clinical assessment
Patients on these combination regimens may require dose adjustments of concurrent diabetes medications to prevent low blood sugar episodes
In AWARD-10 [31], a 24-week, randomized, double-blind, placebo-controlled trial evaluating once-weekly dulaglutide (administered at either 1.5 or 0.75 mg) as add-on therapy to SGLT2is in a total of 424 patients with inadequately controlled T2DM, only one episode of severe hypoglycemia was reported throughout the study, in a patient treated with dulaglutide 0.75 mg, confirming the very low incidence of serious hypoglycemia with GLP-1RAs in combination with SGLT2is [31]
.jpg)
